Adenocarcinoma of the Appendix - 23 Studies Found

Recruiting : Non Ivasive Prenatal Diagnosis (NIPD) of Cystic Fibrosis
: Noninvasive Mucinous Cystadenocarcinoma of Ovary
: 2014-04-22
: Other: A sampling of blood A sampling of blood de 14 ml
Recruiting : Crossover Trial of Systemic Chemotherapy in Patients With Metastatic Well-Differentiated Mucinous Appendiceal Adenocarcinomas With Pseudomyxoma Peritonei
: Gastrointestinal Neoplasms
: 2013-09-12
: Behavioral: Questionnaire Completion of 3 questionnaires a
Recruiting : Postoperative Chemotherapy in High-Grade Appendiceal Adenocarcinoma With Peritoneal Carcinomatosis
: Cancer
: 2015-04-14
: Drug: systemic chemotherapy twelve months of 5-FU or capecitabine with bevacizumab starting 4-8 weeks af
Completed : Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III-IV Clear Cell Ovarian Cancer
:
  • Ovarian Clear Cell Cystadenocarcinoma
  • Stage III Ovarian Cancer<
    : 2010-09-04
    :
    • Drug: Carboplatin Given IV
Active, not recruiting : Selumetinib in Treating Woman With Recurrent Low-Grade Ovarian Cancer or Peritoneum Cancer
:
  • Borderline Ovarian Surface Epithelial-stromal Tumor
  • Ovarian Serous Cys
    : 2007-10-22
    :
    • Drug: selumetinib Given PO
Terminated : Endoscopic Ultrasound (EUS) Guided Ethanol With Paclitaxel Ablation for Pancreatic Mucinous Cystic Neoplasm
:
  • Mucinous Cystic Tumor With Moderate Dysplasia
  • Mucinous Cystadenoma of Pancreas
  • : 2012-02-01
    : Drug: Ethanol and Paclitaxel Injection Endoscopic ultrasound will be used to locate and assess the pancr
Completed : Edrecolomab in Treating Patients With Stage II Colon Cancer
:
  • Mucinous Adenocarcinoma of the Colon
  • Signet Ring Adenocarcinoma
    : 1999-11-01
    :
    • Biological: edrecolomab Given

Recruiting : Biomarkers for Early Detection of Ovarian Cancer Using Uterine Lavage
:
  • Ovarian Cancer
  • Ovarian Carcinoma
  • Fallopian Tube Cancer : 2017-05-03
    :
    • Procedure: Uterine lavage Uter
Not yet recruiting : Proof-of-concept Study of Birinapant in Combination With Platinum Based Chemotherapy in Subjects With High Grade Serous Carcinomas
: Advanced Newly Diagnosed or Recurrent High Grade Serous Carcinomas (HGSC)
: 2016-04-22
:
  • Drug: Birinapant Birinapant -

Recruiting : A Phase II Evaluation of Afatinibin Patients With Persistent or Recurrent HER2-positive Uterine Serous Carcinoma
: HER2/Neu+ Uterine Serous Carcinoma
: 2015-07-02
: Drug: Afatinib Afatinib, 40 mg orally once daily on a 21 day cycle for the first 12 weeks, then every 28
Next >>>